GROUP LEADER
KAROLINA LOUVANTO
Dr. Louvanto MD, PhD, specialist in obstetrics and gynecology started as a tenure track Professor in Obstetrics and Gynecology at Faculty of Medicine and Health Technology, Tampere University in fall 2020. She holds her Medical degree (2006), PhD (2011), Title of docent in the experimental science of obstetrics and gynecology (2018) and Specialist degree in obstetrics and gynecology (2019) from University of Turku, Finland. She did her post-doctoral fellowship in cancer epidemiology at McGill University, Montreal, Canada (2012-2014, 2015) and was a senior clinical fellow in molecular epidemiology at Queen Mary University of London, London, UK (2016-2017). In addition, she has also done extended clinical and research periods in Sweden, Australia, US and Canada. She has received research awards from the National Graduate School of Clinical Investigation (2011), the Duodecim Society of Turku (2012) and the Seth Wichman award in 2019 from the Finnish Society of Obstetrics and Gynaecology.
Her research interests encompass to provide in-depth understanding on the variables and molecular epidemiology that involve human Papillomavirus (HPV) – infection and the disease progression. Her projects are more specifically investigating the impact of childhood HPV-infections consequences in adulthood; identifying better epigenetic or genetic biomarkers to identify women in risk for cervical cancer development and evaluating the role of these biomarkers in cervical cancer screening; and finally also evaluating the future cervical cancer screening tolls and guidelines for HPV vaccinated women. In addition, she is also involved with several research projects nationally and internationally.
Her research is funded by the Academy of Finland, the Sigrid Juselius Foundation, the Finnish Medical Foundation, Finnish Cancer Foundation, Government special funding for Tampere University Hospital and Päivikki and Sakari Sohlberg Foundation.
Contact tenure track Professor Louvanto by e-mail: karolina.louvanto@tuni.fi
SENIOR RESEARCHERS
IVANA KHOLOVÁ
Ivana Kholová, MD, PhD graduated from Faculty of Medicine in Hradec Králové, Charles University in Prague, Czech Republic in 1998 and gained her PhD in pathology at the same university in 2002. She is an Adjunct Professor at the University of Tampere (Pathology, since 2016) and University of Eastern Finland (Experimental Pathology, since 2008).
Nowadays she works as a clinical lecturer at the Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland and serves as a Head of Cytopathology at Fimlab Laboratories located at Tampere University Hospital, where she is involved in HPV screening program.
Her research interests include fine-needle aspiration biopsies of thyroid and salivary glands, cytology-histology correlations and HPV screening and gynecytology. In addition she has also cardiovascular pathology projects.
Since 2015 she is a President of Finnish Society for Clinical Cytology. She works as a Scientific Councillor at European Federation of Cytological Societies Board, where she leads several projects.
She is a co-author of The Milan System for Reporting Salivary Gland Cytopathology. She is an expert member of Executive Editorial Board of The WHO System for Reporting Cytopathology of Lung. Dr. Kholová is an Associate Editor in Acta Cytologica and Cytopathology journals.
Contact Adjunct Professor Kholová by e-mail: ivana.kholova@tuni.fi
LAURA KOTANIEMI-TALONEN
Dr. Kotaniemi-Talonen has a Medical Degree (MD) from the University of Helsinki (2004). She has worked previously as a researched in Mass Screening Registry of Finnish Cancer Registry, and her PhD thesis (2009, University of Helsinki) in Obstetrics and Gynecology concerned cervical cancer screening. Since then, she has specialised in Obstetrics and Gynecology in Tampere University (2018). Currently she is employed by Tampere University and Tampere University Hospital as a clinical lecturer, specialist and certified colposcopist.
Her research projects concern e.g. alternative cervical cancer screening methods, especially HPV screening. As a member of the Current Care Guidelines group, she has been involved with updating the national recommendations for treatment and follow-up of cervical, vaginal and vulvar lesions. She is currently the president of Finnish Colposcopy Society.
Contact Dr. Kotaniemi-Talonen by e-mail: laura.kotaniemi-talonen@tuni.fi
PRESENT STUDENTS
LAURA BERGQVIST
Dr. Bergqvist has received her Medical Degree from the University of Tampere in 1999 and has a specialist degree in Obstetrics and Gynecology. Currently, she is working at Helsinki University Hospital, in the department of Obstetrics and Gynecology.
Her PhD research project is composed of the following three projects. Firstly she is evaluating the diverse behavioural and reproductive factors association with different HPV-genotype prevalence among women referred to colposcopy. Her second project is to determine whether the use of electrical impedance spectroscopy (EIS) device improves colposcopic performance and increases the detection rate of cervical intraepithelial neoplasia grade 2+ (CIN2+). The third project is to investigate the regression and progression rates of cervical intraepithelial neoplasia (CIN2) in a prospective 2-year follow-up study among women thirty years of age or younger.
Contact Dr. Bergqvist by e-mail: laura.bergqvist@hus.fi
VERONIKA FONAGY
Dr. Fonagy received her Medical Degree (MD) from the University of Szeged, in Hungary in 2019 and she is working as a second-year resident in Clinical Microbiology at Fimlab Laboratories. During university she did her medical advanced studies in Obstetrics and Gynecology and wrote her thesis on the effects of successful vaginal birth after caesarean section on the newborns condition.
Veronika joined our team in May 2022 and her current research project is about HPV genotyping by multiplex real-time PCR using technology, which makes it possible to detect and differentiate target nucleic acids of 19 high-risk and 9 low-risk HPV-types.
Contact Dr. Fonagy by email: veronika.fonagy-mogyoros@fimlab.fi
KATARIINA HELASMÄKI
Katariina Helasmäki is currently a 3rd year Biotechnology and Biomedical engineering student at Tampere University.
Currently she is working at Fimlab and assisting with the extended HPV genotyping project of ICARUS. This work will also be part of her bachelor’s thesis, where she will evaluate the differences between the used HPV genotyping methods.
Contact Katariina Helasmäki by e-mail: katariina.helasmaki@tuni.fi
ANNA JAAKOLA
Dr Jaakola received her Medical degree from the University of Turku in 2012 and further specialised into Obstetrics and Gynecology during 2012-2018. Currently she is working in the Kymenlaakso Central hospital.
She is a PhD student in Obstetrics and Gynecology. Her research project involves detailed characterisation of the HLA-G polymorphism and its interaction and associations with HPV infections persistence and disease progression.
Contact Dr. Jaakola by e-mail: ajjaak@utu.fi
TIINA KOIVISTO
Dr. Koivisto received Medical Degree from the Tampere University in 2016. Currently she is working as a resident in Obstetrics and Gynecology in Tampere University Hospital.
Her PhD research project evaluates HPV vaccinations impact on women’s fertility and pregnancy outcomes. The first study compares pregnancy and childbirth prevalence between HPV vaccinated, Hepatitis B-virus (HBV) vaccinated and unvaccinated women. Other future studies will compare a wide range of reproductive and fertility related questions among the HPV vaccinated and unvaccinated women.
Contact Dr. Koivisto by email: tiina.h.koivisto@tuni.fi
AARNO LEINO
Aarno Leino began his studies at Tampere University at the Faculty of Medicine and Health Technology in 2021 and is now a second year medical student.
He is currently working on his medical advanced studies with HPV-related research project. Aim of the project is to evaluate the role of extended HPV genotyping in cervical cancer screening using data gathered from the past ten years from the Tampere region.
Contact Aarno Leino by e-mail: aarno.leino@tuni.fi
SIIRI LEPPÄLÄ
Siiri Leppälä graduated from Etelä-Tapiola high school in 2018. She began her medical studies at the University of Tampere in 2019.
Currently she doing her medical advanced studies and participating in a research project on evaluating HPV vaccine-induced protective serum antibody levels among HPV vaccinated women whom develop HPV induced cervical precancer lesions.
Contact Siiri by e-mail: siiri.leppala@tuni.fi
EKA LUHTANEN
Eka Luhtanen is a fourth-year medical student at Tampere University, Faculty of Medicine and Health Technology.
At present he is working on his medical advanced studies by taking part in a project whose aim is to evaluate the risk factors leading to the need to perform recurring loop electrosurgical excision procedure (LEEP) -treatment on patients with HPV-induced cervical dysplasia and cancer.
Contact Eka by email: eka.luhtanen@tuni.fi
LAURA MUHONEN
Laura started her medical studies at Tampere University in 2020. She previously graduated as a pharmacist from the University of Eastern Finland in 2018.
Currently she is doing her medical advanced studies, which aim is to investigate the effects of co-factors on women’s HPV antibody levels as a part of Finnish Family HPV study.
Contact Laura Muhonen by e-mail: laura.muhonen@tuni.fi
EERO NUMMINEN
Eero started his medical studies at the Tampere University in the Faculty of Medicine in 2021.
He is currently working on his medical advanced studies by participating in a project on different HPV-types as factors in cervical cancer progression. The data for the project is composed of the cervical cancer screening population in Tampere region.
Contact Eero Numminen by e-mail: eero.numminen@tuni.fi
HANNA PIKKUJÄMSÄ
Hanna Pikkujämsä started her medical studies at Tampere University in 2020.
She is currently working on her medical advanced studies on evaluating the effect of the covid-19 pandemic on gynecological cancer care.
Contact Hanna Pikkujämsä by e-mail: hanna.pikkujamsa@tuni.fi
SUVI RINTALA
Suvi Rintala started her medical studies at Tampere University in 2020.
She finalised her medical advanced studies in 2022 by evaluating different cancer screening and prevention guidelines to provide more feasible summaries for the clinicians for their everyday practise. After that she has continued her research towards her PhD degree evaluating the microbiome and virome profiles among the oral and genital HPV infection outcomes.
Contact Suvi by email: suvi.rintala@tuni.fi
HELMI SUOMINEN
Helmi Suominen is a fifth year medical student at the Tampere University. She has worked previously as a research assistant in Tampere University Hospital and Finnish Clinical Biobank Tampere during the summer 2020.
She is currently working towards her PhD degree in Obstetrics and Gynecology. Her studies are evaluating the role different of T-cell markers as other serological responses in persistent genital and oral HPV- infections between the mothers and their children among the Finnish Family HPV study.
Contact Helmi by e-mail: helmi.suominen@tuni.fi
NELLI SUOMINEN
Dr. Suominen received Medical Degree (MD) from the University of Turku in 2019. She is a resident in Obstetrics and gynecology and currently working at the Vaasa Central Hospital.
She is a PhD student in Obstetrics and Gynecology and her research project is about HPV infection susceptibility and HPV co-occurrence between family members. The aim of the research is to evaluate the genetical and immunological risk factors of HPV infection and examine the dynamics of HPV transmission between family members.
Contact Dr. Suominen by e-mail: nelli.t.suominen@utu.fi
KAISA TAAVELA
Dr. Taavela received her Medical Degree from Tampere University in 2014. Currently she is working as a resident in Obstetrics and Gynecology in Tampere University Hospital.
She is a PhD student in Obstetrics and Gynecology. Her research project evaluates HPV infections natural history among couples. The primary aim is to provide better understanding on multisite HPV transmission between couples and factors that influence possible HPV persistence or carcinogenesis. Secondary aim is to evaluate sexuality and quality of life among women undergoing loop electrosurgical excision procedure (LEEP).
Contact Dr. Taavela by e-mail: kaisa.taavela@tuni.fi